SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001104659-12-032225
Filing Date
2012-05-03
Accepted
2012-05-03 06:09:33
Documents
14
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a12-8756_110q.htm 10-Q 646618
2 EX-5.1 a12-8756_1ex5d1.htm EX-5.1 13265
3 EX-10.1 a12-8756_1ex10d1.htm EX-10.1 311215
4 EX-10.2 a12-8756_1ex10d2.htm EX-10.2 40151
5 EX-31.1 a12-8756_1ex31d1.htm EX-31.1 11739
6 EX-31.2 a12-8756_1ex31d2.htm EX-31.2 12191
7 EX-32.1 a12-8756_1ex32d1.htm EX-32.1 8157
14 GRAPHIC g87561kci001.jpg GRAPHIC 2636
  Complete submission text file 0001104659-12-032225.txt   3025840

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT snta-20120331.xml EX-101.INS 295382
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT snta-20120331.xsd EX-101.SCH 17936
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT snta-20120331_cal.xml EX-101.CAL 44422
11 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT snta-20120331_lab.xml EX-101.LAB 271983
12 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT snta-20120331_pre.xml EX-101.PRE 126456
13 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT snta-20120331_def.xml EX-101.DEF 80069
Mailing Address
Business Address 45 HARTWELL AVE LEXINGTON MA 02421 781-274-8200
SYNTA PHARMACEUTICALS CORP (Filer) CIK: 0001157601 (see all company filings)

IRS No.: 000000000
Type: 10-Q | Act: 34 | File No.: 001-33277 | Film No.: 12807224
SIC: 2834 Pharmaceutical Preparations